Clinuvel Pharmaceuticals Limited (CLVLY) Shareholder/Analyst Call Transcript

Group 1 - CLINUVEL Pharmaceuticals Limited held its 2025 Annual General Meeting (AGM) in Melbourne, with a quorum present to conduct formal business [1] - The meeting acknowledged the traditional owners of the land and paid respects to Aboriginal peoples and their cultures [2] - Several non-executive directors attended the meeting, with some joining online from the United States [3] Group 2 - Key executives present included the Managing Director and CEO, Chief Operating Officer, Chief Financial Officer, Head of Investor Relations, and Company Secretary [4]